GENFIT Share Price OTC Markets
Stocks
GNFTF
FR0004163111
Biotechnology & Medical Research
OTC Markets Traded|
Delayed
OTC Markets
07:30:08 24/08/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 15.75 USD | -3.26% |
|
-.--% | +162.50% |
| 11:48am | French and Benelux stocks-Factors to watch on September 15 | RE |
| 10:23am | France's Genfit Plans Phase 2a Trial of Liver Failure Treatment | MT |
| Market Cap | 62Cr 72Cr 59Cr 53Cr 100.26Cr 6.91TCr 100.99Cr 703.63Cr 271.13Cr 3.5TCr 270.61Cr 264.64Cr 11TCr | P/E 2026 * |
32.1x | P/E 2027 * | 71.2x |
|---|---|---|---|---|---|
| Enterprise Value | 57Cr 66Cr 54Cr 49Cr 92Cr 6.34TCr 93Cr 646.03Cr 248.94Cr 3.22TCr 248.46Cr 242.98Cr 10TCr | EV / Sales 2026 * |
5.72x | EV / Sales 2027 * | 4.38x |
| Free-Float |
86.89% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Euronext Paris
| GNFT | Real-time | |
CBOE
| GNFTp | Real-time | |
|
Börse Stuttgart
| XUP | Delayed | |
|
Tradegate
| XUP | Real-time | |
|
CBOE
| 0QT6 | Real-time | |
|
OTC Markets
| GNFTF | Delayed | |
|
Xetra
| XUP | Delayed | |
|
Boerse Muenchen
| XUP | Real-time | |
|
Deutsche Boerse AG
| XUP | Delayed | |
|
London S.E.
| 0QT6 | Delayed |
Last Transcript: GENFIT
| 1 day | -3.26% | ||
| 1 month | -1.25% | ||
| 3 months | +57.82% | ||
| 6 months | +44.76% | ||
| Current year | +162.50% |
| 1 month | 15.75 |  | 16.5 |
| Current year | 7.26 | | 16.5 |
| 1 year | 4.14 | | 16.5 |
| 3 years | 2.95 | | 16.5 |
| 5 years | 2.95 | | 16.5 |
| 10 years | 0 | | 36.86 |
| Manager | Title | Age | Since |
|---|---|---|---|
Pascal Prigent
CEO | Chief Executive Officer | 58 | 16/09/2019 |
Thomas Baetz
DFI | Director of Finance/CFO | 52 | 22/04/2021 |
Pejvack Motlagh
CTO | Chief Tech/Sci/R&D Officer | - | 27/11/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 70 | 16/06/2017 | |
| Director/Board Member | 54 | 15/09/1999 | |
| Director/Board Member | 58 | 16/06/2017 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.26% | -.--% | - | - | 72Cr | |
| -0.39% | -4.57% | -3.03% | +6.67% | 4.56TCr | |
| -1.66% | -1.86% | +340.38% | +540.60% | 4.4TCr | |
| +0.85% | +3.08% | +43.67% | +26.20% | 4.37TCr | |
| -1.09% | +0.80% | +6.63% | +76.87% | 4.02TCr | |
| +0.34% | -4.03% | +9.34% | +38.90% | 3.19TCr | |
| -11.28% | -10.02% | - | - | 1.74TCr | |
| +0.65% | +0.70% | +19.86% | +112.52% | 1.66TCr | |
| +1.03% | +2.30% | +15.47% | +31.58% | 1.45TCr | |
| +0.29% | -3.83% | +77.36% | +29.89% | 1.3TCr | |
| Average | -1.44% | -1.73% | +63.71% | +107.90% | 2.97TCr | |
| Weighted average by Cap. | -0.91% | -2.01% | +75.59% | +129.30% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 10Cr 12Cr 9.46Cr 8.59Cr 16Cr 1.11TCr 16Cr 113.03Cr 44Cr 562.74Cr 43Cr 43Cr 1.79TCr | 13Cr 15Cr 12Cr 11Cr 20Cr 1.4TCr 21Cr 143.15Cr 55Cr 712.73Cr 55Cr 54Cr 2.27TCr |
| Net income | 2.29Cr 2.64Cr 2.16Cr 1.96Cr 3.67Cr 253.06Cr 3.7Cr 26Cr 9.94Cr 128.38Cr 9.92Cr 9.7Cr 408.13Cr | 8L 9L 8L 7L 12.85L 8.85Cr 12.94L 90.16L 34.74L 4.49Cr 34.68L 33.91L 14Cr |
| Net Debt | -5.11Cr -5.9Cr -4.82Cr -4.38Cr -8.21Cr -565.31Cr -8.27Cr -58Cr -22Cr -286.78Cr -22Cr -22Cr -911.72Cr | -6.76Cr -7.8Cr -6.38Cr -5.78Cr -11Cr -747.28Cr -11Cr -76Cr -29Cr -379.09Cr -29Cr -29Cr -1.21TCr |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- GNFT Stock
- GNFTF Stock
Select your edition
All financial news and data tailored to specific country editions
